创伤后应激障碍动物模型现状:行为与生物学表型及转化挑战
综述超过600篇文章,评估当前啮齿类模型除行为表型外探测PTSD生物学表型的能力,发现多数模型可靠产生持久焦虑/抑郁样行为、恐惧回路过度活跃及糖皮质激素受体超敏,但睡眠、免疫、影像及雌性、年龄跨度、时间轨迹研究不足,呼吁更多采用跨物种同源客观指标以提升转化预测性。
要点
- 多数啮齿类PTSD模型可靠产生持久广泛性焦虑样或抑郁样行为、恐惧回路过度活跃和糖皮质激素受体超敏。
- 少数范式探测恐惧条件化/消退或采用外周免疫、睡眠、无创影像措施,应更多纳入以增强转化。
- 缺乏雌性、不同年龄及应激后表型时间轨迹数据,影响模型效度和治疗研究设计。
核心结论
- 临床与临床前科学家合作提高PTSD动物模型可预测性,需更多纳入跨物种同源客观生物学指标以支持药物疗效转化。
研究设计与样本
- 综述超过600篇文章,评估当前啮齿类模型探测PTSD生物学表型(如睡眠障碍、海马与恐惧回路功能障碍、炎症、糖皮质激素受体超敏)及行为表型的能力。
主要发现
- 多数模型可靠产生持久广泛性焦虑样或抑郁样行为,以及恐惧回路过度活跃、糖皮质激素受体超敏和对长期选择性5-羟色胺再摄取抑制剂的反应。
- 少数范式探测恐惧条件化/消退或采用外周免疫、睡眠、无创影像措施。
- 缺乏雌性受试者、不同年龄受试者或应激后表型时间轨迹数据以告知模型效度和治疗研究设计。
临床怎么用
- 临床前和临床PTSD研究者日益纳入同源生物学措施评估风险、反应和治疗结局标志物。
- 该转变有望支持药物疗效从动物模型向临床试验转化,并可能改善II期对III期临床试验的预测性。
局限性
- PTSD为异质性疾病且症状≥20种,建模具有挑战性。
- 缺乏雌性、不同年龄及应激后表型时间轨迹数据,且睡眠、免疫、影像等措施应用不足。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Increasing predictability of animal models of posttraumatic stress disorder (PTSD) has required active collaboration between clinical and preclinical scientists. Modeling PTSD is challenging, as it is a heterogeneous disorder with ≥20 symptoms. Clinical research increasingly utilizes objective biological measures (e.g., imaging, peripheral biomarkers) or nonverbal behaviors and/or physiological responses to complement verbally reported symptoms. This shift toward more-objectively measurable phenotypes enables refinement of current animal models of PTSD, and it supports the incorporation of homologous measures across species. We reviewed >600 articles to examine the ability of current rodent models to probe biological phenotypes of PTSD (e.g., sleep disturbances, hippocampal and fear-circuit dysfunction, inflammation, glucocorticoid receptor hypersensitivity) in addition to behavioral phenotypes. Most models reliably produced enduring generalized anxiety-like or depression-like behaviors, as well as hyperactive fear circuits, glucocorticoid receptor hypersensitivity, and response to long-term selective serotonin reuptake inhibitors. Although a few paradigms probed fear conditioning/extinction or utilized peripheral immune, sleep, and noninvasive imaging measures, we argue that these should be incorporated more to enhance translation. Data on female subjects, on subjects at different ages across the life span, or on temporal trajectories of phenotypes after stress that can inform model validity and treatment study design are needed. Overall, preclinical (and clinical) PTSD researchers are increasingly incorporating homologous biological measures to assess markers of risk, response, and treatment outcome. This shift is exciting, as we and many others hope it not only will support translation of drug efficacy from animal models to clinical trials but also will potentially improve predictability of stage II for stage III clinical trials.
引用
- Deslauriers J, Toth M, Der-Avakian A, et al. Current Status of Animal Models of Posttraumatic Stress Disorder: Behavioral and Biological Phenotypes, and Future Challenges in Improving Translation. Biol Psychiatry. 2017. PMID: 29338843. doi:10.1016/j.biopsych.2017.11.019
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。